CERO · Cero Therapeutics Holdings, Inc. · Investor Relations
$0.07
-0.02 (-25.26%)
At close · Oct 31
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year from the date these unaudited condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$716,309
Shares
71.63M
Volume · Oct 31
7.27M
Avg daily vol (3M)
2.14M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-01-07 | CERo Therapeutics Shareholder Update | Shareholder meeting |
| 2025-10-22 | CERo Therapeutics to Participate in Stem Cell Therapy Panel at the Maxim Growth Summit 2025 | Event |
| 2025-03-12 | CERo Therapeutics Holdings, Inc. to Present Data at the Society for Immunotherapy of Cancer Spring Scientific March 12-14 | Event |
Source: https://www.cero.bio/investors